Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?

Caraci F, Coluzzi F, Marinangeli F, Mercadante S, Rinonapoli G, Romualdi P, Nicora M, Dickenson AH.

Curr Med Res Opin. 2019 Dec 11:1. doi: 10.1080/03007995.2019.1703664. [Epub ahead of print] Retraction in: Curr Med Res Opin. 2020 Jan 29;:1.

PMID:
31822137
2.

NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area.

Borruto AM, Fotio Y, Stopponi S, Brunori G, Petrella M, Caputi FF, Romualdi P, Candeletti S, Narendran R, Rorick-Kehn LM, Ubaldi M, Weiss F, Ciccocioppo R.

Br J Pharmacol. 2019 Nov 12. doi: 10.1111/bph.14915. [Epub ahead of print]

PMID:
31713848
3.

Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.

Domi E, Caputi FF, Romualdi P, Domi A, Scuppa G, Candeletti S, Atkins A, Heilig M, Demopulos G, Gaitanaris G, Ciccocioppo R, Ubaldi M.

J Neurosci. 2019 Dec 4;39(49):9864-9875. doi: 10.1523/JNEUROSCI.1922-19.2019. Epub 2019 Nov 4.

PMID:
31685649
4.

Novel insights on the management of pain: highlights from the 'Science of Relief' meeting.

Anand P, Dickenson A, Finco G, Marinangeli F, Polati E, Romualdi P, Tzschentke TM, Canonico PL.

Pain Manag. 2019 Nov;9(6):521-533. doi: 10.2217/pmt-2019-0031. Epub 2019 Sep 2.

5.

Modulation of the Negative Affective Dimension of Pain: Focus on Selected Neuropeptidergic System Contributions.

Caputi FF, Rullo L, Stamatakos S, Candeletti S, Romualdi P.

Int J Mol Sci. 2019 Aug 17;20(16). pii: E4010. doi: 10.3390/ijms20164010. Review.

6.

Tapentadol for neuropathic pain: a review of clinical studies.

Freo U, Romualdi P, Kress HG.

J Pain Res. 2019 May 16;12:1537-1551. doi: 10.2147/JPR.S190162. eCollection 2019. Review.

7.

Pharmacological rationale for tapentadol therapy: a review of new evidence.

Romualdi P, Grilli M, Canonico PL, Collino M, Dickenson AH.

J Pain Res. 2019 May 16;12:1513-1520. doi: 10.2147/JPR.S190160. eCollection 2019. Review.

8.

Interplay between the Endogenous Opioid System and Proteasome Complex: Beyond Signaling.

Caputi FF, Rullo L, Stamatakos S, Candeletti S, Romualdi P.

Int J Mol Sci. 2019 Mar 21;20(6). pii: E1441. doi: 10.3390/ijms20061441. Review.

9.

Short-term withdrawal from repeated exposure to cocaine during adolescence modulates dynorphin mRNA levels and BDNF signaling in the rat nucleus accumbens.

Caputi FF, Caffino L, Candeletti S, Fumagalli F, Romualdi P.

Drug Alcohol Depend. 2019 Apr 1;197:127-133. doi: 10.1016/j.drugalcdep.2019.01.006. Epub 2019 Feb 13.

10.

Regulation of the Genes Encoding the ppN/OFQ and NOP Receptor.

Caputi FF, Romualdi P, Candeletti S.

Handb Exp Pharmacol. 2019;254:141-162. doi: 10.1007/164_2018_196.

PMID:
30689088
11.

Tapentadol: an analgesic that differs from classic opioids due to its noradrenergic mechanism of action.

Caputi FF, Nicora M, Simeone R, Candeletti S, Romualdi P.

Minerva Med. 2019 Feb;110(1):62-78. doi: 10.23736/S0026-4806.18.05909-8. Review.

PMID:
30667206
12.

The therapeutic potential of novel kappa opioid receptor-based treatments.

Mercadante S, Romualdi P.

Curr Med Chem. 2019 Jan 21. doi: 10.2174/0929867326666190121142459. [Epub ahead of print]

PMID:
30666905
13.

Evidence of a PPARγ-mediated mechanism in the ability of Withania somnifera to attenuate tolerance to the antinociceptive effects of morphine.

Caputi FF, Rullo L, Acquas E, Ciccocioppo R, Candeletti S, Romualdi P.

Pharmacol Res. 2019 Jan;139:422-430. doi: 10.1016/j.phrs.2018.11.033. Epub 2018 Nov 29.

PMID:
30503841
14.

Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats.

Carboni L, Romoli B, Bate ST, Romualdi P, Zoli M.

Drug Alcohol Depend. 2018 Aug 1;189:12-20. doi: 10.1016/j.drugalcdep.2018.04.027. Epub 2018 May 29.

PMID:
29857328
15.

Dynorphinergic system alterations in the corticostriatal circuitry of neuropathic mice support its role in the negative affective component of pain.

Palmisano M, Caputi FF, Mercatelli D, Romualdi P, Candeletti S.

Genes Brain Behav. 2019 Jul;18(6):e12467. doi: 10.1111/gbb.12467. Epub 2018 Mar 15.

PMID:
29430855
16.

The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells.

Caputi FF, Acquas E, Kasture S, Ruiu S, Candeletti S, Romualdi P.

BMC Complement Altern Med. 2018 Jan 10;18(1):9. doi: 10.1186/s12906-017-2065-9.

17.

Assessment and treatment of breakthrough cancer pain: from theory to clinical practice.

Vellucci R, Mediati RD, Gasperoni S, Mammucari M, Marinangeli F, Romualdi P.

J Pain Res. 2017 Sep 12;10:2147-2155. doi: 10.2147/JPR.S135807. eCollection 2017. Review.

18.

The challenge of perioperative pain management in opioid-tolerant patients.

Coluzzi F, Bifulco F, Cuomo A, Dauri M, Leonardi C, Melotti RM, Natoli S, Romualdi P, Savoia G, Corcione A.

Ther Clin Risk Manag. 2017 Sep 5;13:1163-1173. doi: 10.2147/TCRM.S141332. eCollection 2017. Review.

19.

Mystic Acetaldehyde: The Never-Ending Story on Alcoholism.

Peana AT, Sánchez-Catalán MJ, Hipólito L, Rosas M, Porru S, Bennardini F, Romualdi P, Caputi FF, Candeletti S, Polache A, Granero L, Acquas E.

Front Behav Neurosci. 2017 May 11;11:81. doi: 10.3389/fnbeh.2017.00081. eCollection 2017. Review.

20.

From acute to chronic pain: tapentadol in the progressive stages of this disease entity.

Coluzzi F, Fornasari D, Pergolizzi J, Romualdi P.

Eur Rev Med Pharmacol Sci. 2017 Apr;21(7):1672-1683. Review.

21.

Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for alzheimer's disease, a case report.

D'Addario C, Candia SB, Arosio B, Di Bartolomeo M, Abbate C, Casè A, Candeletti S, Romualdi P, Damanti S, Maccarrone M, Bergamaschini L, Mari D.

J Neurol Sci. 2017 Jan 15;372:211-216. doi: 10.1016/j.jns.2016.11.052. Epub 2016 Nov 24.

PMID:
28017215
22.

N/OFQ system in brain areas of nerve-injured mice: its role in different aspects of neuropathic pain.

Palmisano M, Mercatelli D, Caputi FF, Carretta D, Romualdi P, Candeletti S.

Genes Brain Behav. 2017 Jun;16(5):537-545. doi: 10.1111/gbb.12365. Epub 2017 Jan 10.

23.

Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure.

Caputi FF, Palmisano M, Carboni L, Candeletti S, Romualdi P.

Pharmacol Res. 2016 Dec;114:209-218. doi: 10.1016/j.phrs.2016.10.023. Epub 2016 Oct 29.

PMID:
27989838
24.

Alghedon Fentanyl Transdermal System.

Romualdi P, Santi P, Candeletti S.

Minerva Med. 2017 Apr;108(2):169-175. doi: 10.23736/S0026-4806.16.04930-2. Epub 2016 Nov 25. Review.

PMID:
27886163
25.

Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway.

Carboni L, Romoli B, Romualdi P, Zoli M.

Drug Alcohol Depend. 2016 Sep 1;166:150-8. doi: 10.1016/j.drugalcdep.2016.07.002. Epub 2016 Jul 12.

PMID:
27430399
26.

Reply-Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.

Working Group Nientemale DEI, Vellucci R, Fanelli G, Cortesi PA, Pannuti R, Peruselli C, Romualdi P.

Drugs. 2016 Jul;76(10):1063-5. doi: 10.1007/s40265-016-0594-z. No abstract available.

27.

Fentanyl citrate sublingual formulation (Vellofent®) for quick BTcP hindering.

Romualdi P, Candeletti S.

Minerva Med. 2016 Apr;107(2):114-22. Review.

PMID:
27064584
28.

Erratum to: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.

Working Group Nientemale DEI, Vellucci R, Fanelli G, Pannuti R, Peruselli C, Adamo S, Alongi G, Amato F, Consoletti L, Lamarca L, Liguori S, Lo Presti C, Maione A, Mameli S, Marinangeli F, Marulli S, Minotti V, Miotti D, Montanari L, Moruzzi G, Palermo S, Parolini M, Poli P, Tirelli W, Valle A, Romualdi P.

Drugs. 2016 Apr;76(6):731-2. doi: 10.1007/s40265-016-0563-6. No abstract available.

29.

Cocaine and ethanol target 26S proteasome activity and gene expression in neuroblastoma cells.

Caputi FF, Carboni L, Mazza D, Candeletti S, Romualdi P.

Drug Alcohol Depend. 2016 Apr 1;161:265-75. doi: 10.1016/j.drugalcdep.2016.02.012. Epub 2016 Feb 16.

PMID:
26922280
30.

Treatment with the neurotoxic Aβ (25-35) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y human neuroblastoma cells.

Lattanzio F, Carboni L, Carretta D, Candeletti S, Romualdi P.

Exp Toxicol Pathol. 2016 May;68(5):271-6. doi: 10.1016/j.etp.2016.02.001. Epub 2016 Feb 22.

PMID:
26915812
31.

What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.

Working Group Nientemale DEI, Vellucci R, Fanelli G, Pannuti R, Peruselli C, Adamo S, Alongi G, Amato F, Consoletti L, Lamarca L, Liguori S, Lo Presti C, Maione A, Mameli S, Marinangeli F, Marulli S, Minotti V, Miotti D, Montanari L, Moruzzi G, Palermo S, Parolini M, Poli P, Tirelli W, Valle A, Romualdi P.

Drugs. 2016 Mar;76(3):315-30. doi: 10.1007/s40265-015-0519-2. Review. Erratum in: Drugs. 2016 Apr;76(6):731-2.

32.

The prevention of analgesic opioids abuse: expert opinion.

Maremmani I, Gerra G, Ripamonti IC, Mugelli A, Allegri M, Viganò R, Romualdi P, Pinto C, Raffaeli W, Coluzzi F, Gatti RC, Mammucari M, Fanelli G.

Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):4203-6. Review.

33.

Proteasome subunit and opioid receptor gene expression down-regulation induced by paraquat and maneb in human neuroblastoma SH-SY5Y cells.

Caputi FF, Carretta D, Lattanzio F, Palmisano M, Candeletti S, Romualdi P.

Environ Toxicol Pharmacol. 2015 Nov;40(3):895-900. doi: 10.1016/j.etap.2015.09.019. Epub 2015 Oct 3.

PMID:
26498265
34.

Effects of acute ethanol exposure on class I HDACs family enzymes in wild-type and BDNF(+/-) mice.

Caputi FF, Palmisano M, D'Addario C, Candeletti S, Romualdi P.

Drug Alcohol Depend. 2015 Oct 1;155:68-75. doi: 10.1016/j.drugalcdep.2015.08.015. Epub 2015 Aug 28.

PMID:
26361715
35.

Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.

Carboni L, Lattanzio F, Candeletti S, Porcellini E, Raschi E, Licastro F, Romualdi P.

Neurosci Lett. 2015 Sep 25;605:44-8. doi: 10.1016/j.neulet.2015.08.012. Epub 2015 Aug 11.

PMID:
26275347
36.

A new potent analgesic agent with reduced liability to produce morphine tolerance.

Kiraly K, Caputi FF, Hanuska A, Kató E, Balogh M, Köles L, Palmisano M, Riba P, Hosztafi S, Romualdi P, Candeletti S, Ferdinandy P, Fürst S, Al-Khrasani M.

Brain Res Bull. 2015 Aug;117:32-8. doi: 10.1016/j.brainresbull.2015.07.005. Epub 2015 Jul 30.

PMID:
26235542
37.

Opioid receptor gene expression in human neuroblastoma SH-SY5Y cells following tapentadol exposure.

Caputi FF, Carretta D, Tzschentke TM, Candeletti S, Romualdi P.

J Mol Neurosci. 2014 Aug;53(4):669-76. doi: 10.1007/s12031-014-0235-5. Epub 2014 Feb 4.

PMID:
24488603
38.

Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: Relevance to sporadic Parkinson's disease.

Bastías-Candia S, Di Benedetto M, D'Addario C, Candeletti S, Romualdi P.

Environ Toxicol. 2015 May-Jun;30(6):656-63. doi: 10.1002/tox.21943. Epub 2013 Dec 23.

PMID:
24376148
39.

Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk.

Fanelli A, Romualdi P, Vigano' R, Lora Aprile P, Gensini G, Fanelli G.

Acta Biomed. 2013 Jun 1;84(1):5-11. Review.

PMID:
24189757
40.

Dynorphin/KOP and nociceptin/NOP gene expression and epigenetic changes by cocaine in rat striatum and nucleus accumbens.

Caputi FF, Di Benedetto M, Carretta D, Bastias del Carmen Candia S, D'Addario C, Cavina C, Candeletti S, Romualdi P.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Mar 3;49:36-46. doi: 10.1016/j.pnpbp.2013.10.016. Epub 2013 Nov 1.

PMID:
24184686
41.

Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.

Lattanzio F, Carboni L, Carretta D, Rimondini R, Candeletti S, Romualdi P.

Neuroscience. 2014 Jan 3;256:360-9. doi: 10.1016/j.neuroscience.2013.10.017. Epub 2013 Oct 23.

PMID:
24161275
42.

The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.

Gallelli L, Galasso O, Falcone D, Southworth S, Greco M, Ventura V, Romualdi P, Corigliano A, Terracciano R, Savino R, Gulletta E, Gasparini G, De Sarro G.

Osteoarthritis Cartilage. 2013 Sep;21(9):1400-8. doi: 10.1016/j.joca.2013.06.026.

43.

Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells.

Caputi FF, Lattanzio F, Carretta D, Mercatelli D, Candeletti S, Romualdi P.

J Mol Neurosci. 2013 Oct;51(2):532-8. doi: 10.1007/s12031-013-0019-3. Epub 2013 May 29.

PMID:
23715695
44.

Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.

Aujla H, Cannarsa R, Romualdi P, Ciccocioppo R, Martin-Fardon R, Weiss F.

Addict Biol. 2013 May;18(3):467-79. doi: 10.1111/j.1369-1600.2012.00466.x. Epub 2012 Jul 15.

45.

Ethanol induces epigenetic modulation of prodynorphin and pronociceptin gene expression in the rat amygdala complex.

D'Addario C, Caputi FF, Ekström TJ, Di Benedetto M, Maccarrone M, Romualdi P, Candeletti S.

J Mol Neurosci. 2013 Feb;49(2):312-9. doi: 10.1007/s12031-012-9829-y. Epub 2012 Jun 10.

PMID:
22684622
46.

Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII.

D'Addario C, Dell'Osso B, Palazzo MC, Benatti B, Lietti L, Cattaneo E, Galimberti D, Fenoglio C, Cortini F, Scarpini E, Arosio B, Di Francesco A, Di Benedetto M, Romualdi P, Candeletti S, Mari D, Bergamaschini L, Bresolin N, Maccarrone M, Altamura AC.

Neuropsychopharmacology. 2012 Jun;37(7):1647-55. doi: 10.1038/npp.2012.10. Epub 2012 Feb 22.

47.

Pin1 contribution to Alzheimer's disease: transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease.

Arosio B, Bulbarelli A, Bastias Candia S, Lonati E, Mastronardi L, Romualdi P, Candeletti S, Gussago C, Galimberti D, Scarpini E, Dell'Osso B, Altamura C, MacCarrone M, Bergamaschini L, D'Addario C, Mari D.

Neurodegener Dis. 2012;10(1-4):207-11. doi: 10.1159/000333799. Epub 2012 Jan 17.

PMID:
22261503
48.

∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells.

Cannarsa R, Carretta D, Lattanzio F, Candeletti S, Romualdi P.

J Mol Neurosci. 2012 Feb;46(2):285-92. doi: 10.1007/s12031-011-9552-0. Epub 2011 May 21.

PMID:
21603976
49.

Different alcohol exposures induce selective alterations on the expression of dynorphin and nociceptin systems related genes in rat brain.

D'Addario C, Caputi FF, Rimondini R, Gandolfi O, Del Borrello E, Candeletti S, Romualdi P.

Addict Biol. 2013 May;18(3):425-33. doi: 10.1111/j.1369-1600.2011.00326.x. Epub 2011 Apr 20.

PMID:
21507157
50.

Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade.

Di Benedetto M, Bastías Candia Sdel C, D'Addario C, Porticella EE, Cavina C, Candeletti S, Romualdi P.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Feb;383(2):169-78. doi: 10.1007/s00210-010-0587-5. Epub 2010 Dec 23.

PMID:
21181116

Supplemental Content

Loading ...
Support Center